IP Library Granted Patent US 9,738,921
Granted Patent B2
US 9,738,921 · App. 14/800,352 · Granted Aug 22, 2017

Compositions and methods for monitoring transmembrane trafficking

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,738,921
App. No.
14/800,352
Granted
Aug 22, 2017
Kind
B2
Abstract

Provided herein are compositions and methods for monitoring the movement of analytes and/or cellular components across biological membranes (e.g., cell surface internalization). In particular, reporter constructs are provided, the transmembrane movement of which (e.g., by endocytosis) is monitored by methods described herein.

Claims (19)

1. A method of detecting endocytosis comprising:

a) expressing a fusion protein in a cell comprising a cell membrane, wherein said fusion protein comprises a cell-surface receptor protein and a reporter protein, and said expressing results in the co-expression of the cell surface receptor protein and the reporter protein as a single fusion protein in the cell, wherein the reporter protein is displayed extracellularly when the cell-surface receptor is incorporated into the cell membrane of the cell;

b) delivering a reporter substrate to the cell, wherein an association between the reporter protein and reporter substrate produces a detectable signal when the association occurs extracellularly and an altered signal when the association occurs intracellularly; and

c) monitoring said detectable signal and said altered signal, wherein a transition from said detectable signal to said altered signal indicates endocytosis of the fusion protein.

2. The method of detecting endocytosis of claim 1 , wherein monitoring of said detectable signal comprises:

i) inducing endocytosis of said fusion protein; and

ii) detecting said detectable signal and said altered signal after inducing endocytosis.

3. The method of detecting endocytosis of claim 1 , wherein monitoring of said detectable signal comprises:

i) detecting said signal prior to endocytosis;

ii) allowing endocytosis of said fusion protein;

iii) detecting said signal following endocytosis; and

iv) comparing said signal from step (i) to said signal from step (iii) to detect endocytosis.

4. The method of claim 1 , wherein said reporter protein comprises a luciferase enzyme.

5. The method of claim 4 , wherein the luciferase enzyme is a beetle or Oplophorus luciferase enzyme or a mutant or variant thereof.

6. The method of claim 1 , wherein endocytosis results in movement of said reporter protein from an extracellular space into an endosome.

7. The method of claim 6 , wherein said signal is detectably altered within said endosome compared to the extracellular space.

8. The method of claim 6 , wherein said signal is reduced within said endosome compared to the extracellular space.

9. The method of claim 1 , wherein said reporter substrate is a luciferin, luciferin derivative, coelenterazine or coelenterazine derivative.

10. The method of claim 3 , further comprising a step between steps (i) and (ii) of triggering endocytosis.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2015
From: BINKOWSKI, BROCK F; CONG, MEI; ROBERS, MATTHEW B.
To: PROMEGA CORPORATION
Reel/Frame 036746/0237 →